Congenital microphthalmia (CM), an eyeball defect, is caused by abnormal embryonic optic vesicle development and is characterized by a reduced eyeball volume and axial diameter. It is a rare congenital disease with an incidence rate of 0.7-1.9 cases per 10,000 persons, at birth, with an incidence rate of 0.22 per 10,000 persons for bilateral microphthalmia. [1] [2] [3] However, data concerning the diagnostic criteria for fetal CM remain limited. We present two rare cases of bilateral CM, involving the same parents, diagnosed using ultrasonography (US) and magnetic resonance imaging (MRI). Genetic testing was performed for both parents and fetuses.
Case Report
This study was approved by the Ethics Committee of Beijing Tongren Hospital, Beijing, China (Approval no: TRECKY2018-005). A 31-year-old Chinese woman (gravida 1, para 0) at 22 +1 weeks of gestation underwent abdominal US; bilateral CM of the fetus was suspected. Abdominal MRI (23 gestation weeks) was performed to confirm the diagnosis [ Fig. 1a and b]. The pregnancy was terminated at parental request after MRI examination, the induced fetus (male) was examined, and CM was confirmed.
Eight months later, the woman became pregnant again. The abdominal US examinations during early pregnancy indicated fetal eye abnormalities. At 22 weeks of the pregnancy, based on abdominal US, bilateral CM was suspected. Abdominal MRI was performed to confirm the diagnosis. US (27 +5 gestation weeks) and MR (26 gestation weeks) images are shown in Fig. 2a-d , respectively. The family received extensive counseling and decided on pregnancy termination at 27 weeks of gestation. The induced fetus (female) was examined and the diagnosis of CM was confirmed based on the following characteristics: short and narrow palpebral fissure length, shallow eye sockets, and small eyeballs [ Fig. 3a Genetic testing in the parents and two fetuses involved extracting DNA from parental blood and fetal skin tissue, respectively, identifying a heterozygous mutation (c. 1532C > G; p.S511W) in GL12, derived from the father. The parents were healthy, and no maternal history of antenatal drug use or X-ray exposure was noted. The parents denied consanguineous marriage or family history of eye malformations. The babies did not show any systemic malformations, including cardiac defects, facial clefts, microcephaly, or hydrocephaly. 
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Discussion
This is a report of two fetuses with bilateral CM, from the same parents, diagnosed using US and MRI. To date, the universal diagnostic criterion for neonatal CM is an axial length of ≤20.0 mm. [4] However, data concerning the diagnostic criteria for fetal CM remain limited. Denis et al. [5] analyzed 108 "normal" fetuses from spontaneous and therapeutic abortions and obtained the mean palpebral fissure length, inner and outer canthal distances, and the axial length of the eyeball (11.71 ± 1.02 mm at 23-25 weeks) at different weeks of gestation. According to the current international US protocols, a diagnosis of CM is rendered when the axial diameter of the eyeball is less than 2 standard deviations below the mean using prenatal US. [6] The eyeball size of the two aborted fetuses was significantly smaller than that observed in gestational age-matched normal fetuses.
CM can have serious effects on orbitofacial development. [7] An ocular examination of the second fetus revealed a short palpebral fissure length, long inner canthal distance, and an outer canthal distance within the normal range, consistent with the ophthalmic features of children with CM. The axial lengths of bilateral eyeballs of the first (23 gestational weeks) and second (27 gestational weeks) fetuses were similar, suggesting that eyeball development of fetuses with CM occurs at early gestational ages. Eyeball development was retarded or inactive at the middle and late gestational ages.
Chromosomal abnormalities, mutations, infection, and antenatal drug exposure are the common underlying causes of CM. [5, 8] Bilateral CM has an incidence rate of 0.22 per 10,000 persons. CM is usually associated with systemic abnormalities (50%-90%) [6] and differential diagnoses of CM include anophthalmos, microcornea, and eyeball atrophy. In the present case, imageological examination and autopsy revealed isolated bilateral microphthalmia without any systemic malformations in the infant siblings. Moreover, the father and the two fetuses had a heterozygous mutation in GL12. Although previously unreported, our results reveal that GL12 mutation may be associated with CM. Prenatal abdominal US is useful for screening fetal CM. However, its accuracy may be affected by gestational age, fetal position, movements, or other factors. MRI is considered safe in the second and third trimesters; [9] unaffected by gestational age, fetal position, or amniotic fluid; and provides more detailed images for detecting ocular abnormalities. Thus, a detailed, targeted MRI with a specific focus on the orbital region should be offered for cases presenting with abnormal prenatal abdominal US. Fetal CM diagnosed with MRI can form a basis for pregnancy termination with mutual consent of the spouses. [10] In our case report, repeated abdominal US during the second trimester of pregnancy were suggestive of CM. Consequently, considering the health of the mother, early pregnancy termination was recommended; however, the parents were hesitant. Both cases were confirmed by MRI, and the parents ultimately made the decision to end the pregnancy. Therefore, clear MR images are conducive to diagnosing CM. The antepartum US and MRI measurements were approximately 25% smaller than the postpartum measurements, suggesting that antepartum measurements must be adjusted for more accurate estimation of eyeball size.
Conclusion
This study revealed that prenatal US screening combined with MRI is a reliable method for diagnosing fetal CM.
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